Literature DB >> 23903772

Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatment.

Louise A Donnelly1, Natalie R van Zuydam, Kaixin Zhou, Roger Tavendale, Fiona Carr, Anke H Maitland-van der Zee, Maarten Leusink, Anthonius de Boer, Pieter A Doevendans, Folkert W Asselbergs, Andrew D Morris, Ewan R Pearson, Olaf H Klungel, Alex S F Doney, Colin N A Palmer.   

Abstract

OBJECTIVES: The LPA single-nucleotide polymorphism rs10455872 has been associated with low-density lipoprotein cholesterol (LDLc) lowering response to statins in several randomized control trials (RCTs) and is a known coronary artery disease (CAD) marker. However, it is unclear what residual risk of CAD this marker may have during statin treatment.
METHODS: Using electronic medical records linked to the GoDARTS genotyped population, we identified over 8000 patients on statins in Tayside, Scotland.
RESULTS: We replicated the findings of the RCTs, with the G allele of rs10455872 being associated with a 0.10 mmol/l per allele poorer reduction in LDLc in response to statin treatment, and conducted a meta-analysis with previously published RCTs (P = 1.46 × 10, n = 30 467). We showed an association between rs10455872 and CAD in statin-treated individuals and have replicated this finding in the Utrecht Cardiovascular Pharmacogenetics study (combined odds ratio 1.41, 95% confidence interval 1.17-1.68, P = 4.5 × 10, n = 8822) suggesting that statin treatment does not abrogate this well-established genetic risk for CAD. Furthermore, in a Cox proportional hazards model with LDLc measured time dependently, we demonstrated that the relationship between CAD and rs10455872 was independent of LDLc during statin treatment.
CONCLUSION: Individuals with the G allele of rs10455872, which represents approximately one in seven patients, have a higher risk of CAD than the majority of the population even after treatment with statins; and therefore represent a vulnerable group requiring an alternative medication in addition to statin treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23903772      PMCID: PMC4110714          DOI: 10.1097/FPC.0b013e3283642fd6

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  25 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Lp(a) concentrations are related to plasma lipid concentrations.

Authors:  D L Rainwater
Journal:  Atherosclerosis       Date:  1996-11-15       Impact factor: 5.162

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease.

Authors:  D E Hilleman; R L Wurdeman; T L Lenz
Journal:  Pharmacotherapy       Date:  2001-04       Impact factor: 4.705

5.  Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study.

Authors:  Alex S F Doney; Simon Lee; Graham P Leese; Andrew D Morris; Colin N A Palmer
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

Review 6.  Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy.

Authors:  Gerd Schmitz; Anna Schmitz-Madry; Peter Ugocsai
Journal:  Curr Opin Lipidol       Date:  2007-04       Impact factor: 4.776

7.  Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study.

Authors:  Alex S F Doney; Bettina Fischer; Graham Leese; Andrew D Morris; Colin N A Palmer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-10-14       Impact factor: 8.311

8.  Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.

Authors:  Louise A Donnelly; Colin N A Palmer; Adrian L Whitley; Chim Choy Lang; Alex S F Doney; Andrew D Morris; Peter T Donnan
Journal:  Pharmacogenet Genomics       Date:  2008-04       Impact factor: 2.089

9.  Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study.

Authors:  L Wei; J Wang; P Thompson; S Wong; A D Struthers; T M MacDonald
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

10.  Biological, clinical and population relevance of 95 loci for blood lipids.

Authors:  Tanya M Teslovich; Kiran Musunuru; Albert V Smith; Andrew C Edmondson; Ioannis M Stylianou; Masahiro Koseki; James P Pirruccello; Samuli Ripatti; Daniel I Chasman; Cristen J Willer; Christopher T Johansen; Sigrid W Fouchier; Aaron Isaacs; Gina M Peloso; Maja Barbalic; Sally L Ricketts; Joshua C Bis; Yurii S Aulchenko; Gudmar Thorleifsson; Mary F Feitosa; John Chambers; Marju Orho-Melander; Olle Melander; Toby Johnson; Xiaohui Li; Xiuqing Guo; Mingyao Li; Yoon Shin Cho; Min Jin Go; Young Jin Kim; Jong-Young Lee; Taesung Park; Kyunga Kim; Xueling Sim; Rick Twee-Hee Ong; Damien C Croteau-Chonka; Leslie A Lange; Joshua D Smith; Kijoung Song; Jing Hua Zhao; Xin Yuan; Jian'an Luan; Claudia Lamina; Andreas Ziegler; Weihua Zhang; Robert Y L Zee; Alan F Wright; Jacqueline C M Witteman; James F Wilson; Gonneke Willemsen; H-Erich Wichmann; John B Whitfield; Dawn M Waterworth; Nicholas J Wareham; Gérard Waeber; Peter Vollenweider; Benjamin F Voight; Veronique Vitart; Andre G Uitterlinden; Manuela Uda; Jaakko Tuomilehto; John R Thompson; Toshiko Tanaka; Ida Surakka; Heather M Stringham; Tim D Spector; Nicole Soranzo; Johannes H Smit; Juha Sinisalo; Kaisa Silander; Eric J G Sijbrands; Angelo Scuteri; James Scott; David Schlessinger; Serena Sanna; Veikko Salomaa; Juha Saharinen; Chiara Sabatti; Aimo Ruokonen; Igor Rudan; Lynda M Rose; Robert Roberts; Mark Rieder; Bruce M Psaty; Peter P Pramstaller; Irene Pichler; Markus Perola; Brenda W J H Penninx; Nancy L Pedersen; Cristian Pattaro; Alex N Parker; Guillaume Pare; Ben A Oostra; Christopher J O'Donnell; Markku S Nieminen; Deborah A Nickerson; Grant W Montgomery; Thomas Meitinger; Ruth McPherson; Mark I McCarthy; Wendy McArdle; David Masson; Nicholas G Martin; Fabio Marroni; Massimo Mangino; Patrik K E Magnusson; Gavin Lucas; Robert Luben; Ruth J F Loos; Marja-Liisa Lokki; Guillaume Lettre; Claudia Langenberg; Lenore J Launer; Edward G Lakatta; Reijo Laaksonen; Kirsten O Kyvik; Florian Kronenberg; Inke R König; Kay-Tee Khaw; Jaakko Kaprio; Lee M Kaplan; Asa Johansson; Marjo-Riitta Jarvelin; A Cecile J W Janssens; Erik Ingelsson; Wilmar Igl; G Kees Hovingh; Jouke-Jan Hottenga; Albert Hofman; Andrew A Hicks; Christian Hengstenberg; Iris M Heid; Caroline Hayward; Aki S Havulinna; Nicholas D Hastie; Tamara B Harris; Talin Haritunians; Alistair S Hall; Ulf Gyllensten; Candace Guiducci; Leif C Groop; Elena Gonzalez; Christian Gieger; Nelson B Freimer; Luigi Ferrucci; Jeanette Erdmann; Paul Elliott; Kenechi G Ejebe; Angela Döring; Anna F Dominiczak; Serkalem Demissie; Panagiotis Deloukas; Eco J C de Geus; Ulf de Faire; Gabriel Crawford; Francis S Collins; Yii-der I Chen; Mark J Caulfield; Harry Campbell; Noel P Burtt; Lori L Bonnycastle; Dorret I Boomsma; S Matthijs Boekholdt; Richard N Bergman; Inês Barroso; Stefania Bandinelli; Christie M Ballantyne; Themistocles L Assimes; Thomas Quertermous; David Altshuler; Mark Seielstad; Tien Y Wong; E-Shyong Tai; Alan B Feranil; Christopher W Kuzawa; Linda S Adair; Herman A Taylor; Ingrid B Borecki; Stacey B Gabriel; James G Wilson; Hilma Holm; Unnur Thorsteinsdottir; Vilmundur Gudnason; Ronald M Krauss; Karen L Mohlke; Jose M Ordovas; Patricia B Munroe; Jaspal S Kooner; Alan R Tall; Robert A Hegele; John J P Kastelein; Eric E Schadt; Jerome I Rotter; Eric Boerwinkle; David P Strachan; Vincent Mooser; Kari Stefansson; Muredach P Reilly; Nilesh J Samani; Heribert Schunkert; L Adrienne Cupples; Manjinder S Sandhu; Paul M Ridker; Daniel J Rader; Cornelia M van Duijn; Leena Peltonen; Gonçalo R Abecasis; Michael Boehnke; Sekar Kathiresan
Journal:  Nature       Date:  2010-08-05       Impact factor: 49.962

View more
  10 in total

Review 1.  The genetics of drug efficacy: opportunities and challenges.

Authors:  Matthew R Nelson; Toby Johnson; Liling Warren; Arlene R Hughes; Stephanie L Chissoe; Chun-Fang Xu; Dawn M Waterworth
Journal:  Nat Rev Genet       Date:  2016-03-14       Impact factor: 53.242

Review 2.  Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.

Authors:  Calvin Yeang; Michael J Wilkinson; Sotirios Tsimikas
Journal:  Curr Opin Cardiol       Date:  2016-07       Impact factor: 2.161

3.  LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins.

Authors:  Wei-Qi Wei; Xiaohui Li; Qiping Feng; Michiaki Kubo; Iftikhar J Kullo; Peggy L Peissig; Elizabeth W Karlson; Gail P Jarvik; Ming Ta Michael Lee; Ning Shang; Eric A Larson; Todd Edwards; Christian M Shaffer; Jonathan D Mosley; Shiro Maeda; Momoko Horikoshi; Marylyn Ritchie; Marc S Williams; Eric B Larson; David R Crosslin; Sarah T Bland; Jennifer A Pacheco; Laura J Rasmussen-Torvik; David Cronkite; George Hripcsak; Nancy J Cox; Russell A Wilke; C Michael Stein; Jerome I Rotter; Yukihide Momozawa; Dan M Roden; Ronald M Krauss; Joshua C Denny
Journal:  Circulation       Date:  2018-10-23       Impact factor: 29.690

Review 4.  Involvement of inflammatory responses in the early development of calcific aortic valve disease: lessons from statin therapy.

Authors:  Seung Hyun Lee; Jae-Hoon Choi
Journal:  Anim Cells Syst (Seoul)       Date:  2018-09-28       Impact factor: 1.815

5.  Modulation of plasma triglycerides concentration by sterol-based treatment in children carrying different genes.

Authors:  Ismael San Mauro Martín; Sara Sanz Rojo; Elena Garicano Vilar; Luis Collado Yurrita; Javier Andrés Blumenfeld Olivares
Journal:  Ann Pediatr Cardiol       Date:  2019 May-Aug

6.  Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.

Authors:  Iris Postmus; Helen R Warren; Stella Trompet; Benoit J Arsenault; Christy L Avery; Joshua C Bis; Daniel I Chasman; Catherine E de Keyser; Harshal A Deshmukh; Daniel S Evans; QiPing Feng; Xiaohui Li; Roelof A J Smit; Albert V Smith; Fangui Sun; Kent D Taylor; Alice M Arnold; Michael R Barnes; Bryan J Barratt; John Betteridge; S Matthijs Boekholdt; Eric Boerwinkle; Brendan M Buckley; Y-D Ida Chen; Anton J M de Craen; Steven R Cummings; Joshua C Denny; Marie Pierre Dubé; Paul N Durrington; Gudny Eiriksdottir; Ian Ford; Xiuqing Guo; Tamara B Harris; Susan R Heckbert; Albert Hofman; G Kees Hovingh; John J P Kastelein; Leonore J Launer; Ching-Ti Liu; Yongmei Liu; Thomas Lumley; Paul M McKeigue; Patricia B Munroe; Andrew Neil; Deborah A Nickerson; Fredrik Nyberg; Eoin O'Brien; Christopher J O'Donnell; Wendy Post; Neil Poulter; Ramachandran S Vasan; Kenneth Rice; Stephen S Rich; Fernando Rivadeneira; Naveed Sattar; Peter Sever; Sue Shaw-Hawkins; Denis C Shields; P Eline Slagboom; Nicholas L Smith; Joshua D Smith; Nona Sotoodehnia; Alice Stanton; David J Stott; Bruno H Stricker; Til Stürmer; André G Uitterlinden; Wei-Qi Wei; Rudi G J Westendorp; Eric A Whitsel; Kerri L Wiggins; Russell A Wilke; Christie M Ballantyne; Helen M Colhoun; L Adrienne Cupples; Oscar H Franco; Vilmundur Gudnason; Graham Hitman; Colin N A Palmer; Bruce M Psaty; Paul M Ridker; Jeanette M Stafford; Charles M Stein; Jean-Claude Tardif; Mark J Caulfield; J Wouter Jukema; Jerome I Rotter; Ronald M Krauss
Journal:  J Med Genet       Date:  2016-09-01       Impact factor: 6.318

7.  Phenotype standardization for statin-induced myotoxicity.

Authors:  A Alfirevic; D Neely; J Armitage; H Chinoy; R G Cooper; R Laaksonen; D F Carr; K M Bloch; J Fahy; A Hanson; Q-Y Yue; M Wadelius; A H Maitland-van Der Zee; D Voora; B M Psaty; C N A Palmer; M Pirmohamed
Journal:  Clin Pharmacol Ther       Date:  2014-06-04       Impact factor: 6.875

8.  Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS).

Authors:  Harry L Hébert; Bridget Shepherd; Keith Milburn; Abirami Veluchamy; Weihua Meng; Fiona Carr; Louise A Donnelly; Roger Tavendale; Graham Leese; Helen M Colhoun; Ellie Dow; Andrew D Morris; Alexander S Doney; Chim C Lang; Ewan R Pearson; Blair H Smith; Colin N A Palmer
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

9.  Genomic Influence in the Prevention of Cardiovascular Diseases with a Sterol-Based Treatment.

Authors:  Ismael San Mauro Martín; Javier Andrés Blumenfeld Olivares; Eva Pérez Arruche; Esperanza Arce Delgado; María José Ciudad Cabañas; Elena Garicano Vilar; Luis Collado Yurrita
Journal:  Diseases       Date:  2018-04-03

Review 10.  Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics.

Authors:  Daniel I Swerdlow; David A Rider; Arash Yavari; Marie Wikström Lindholm; Giles V Campion; Steven E Nissen
Journal:  Cardiovasc Res       Date:  2022-03-25       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.